1. Home
  2. USNA vs AVXL Comparison

USNA vs AVXL Comparison

Compare USNA & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

HOLD

Current Price

$18.90

Market Cap

317.0M

Sector

Health Care

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$3.19

Market Cap

289.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USNA
AVXL
Founded
1992
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
317.0M
289.1M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
USNA
AVXL
Price
$18.90
$3.19
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$22.00
AVG Volume (30 Days)
84.1K
852.5K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.58
N/A
Revenue
$1,060,902,000.00
N/A
Revenue This Year
$3.90
N/A
Revenue Next Year
$6.21
N/A
P/E Ratio
$33.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.60
$2.61
52 Week High
$38.32
$13.99

Technical Indicators

Market Signals
Indicator
USNA
AVXL
Relative Strength Index (RSI) 50.60 43.60
Support Level $18.80 $2.93
Resistance Level $21.21 $3.76
Average True Range (ATR) 0.81 0.18
MACD -0.02 0.01
Stochastic Oscillator 31.45 23.02

Price Performance

Historical Comparison
USNA
AVXL

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: